Real world treatment utilization patterns in patients with castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Real world treatment utilization patterns in patients with castration-resistant prostate cancer

Published:2021-06-07 Issue:4 Volume:55 Page:299-306
ISSN:2168-1805
Container-title:Scandinavian Journal of Urology
language:en
Short-container-title:Scandinavian Journal of Urology

Author:

Vigneswaran Hari T.¹,Warnqvist Anna²,Andersson Therese M. L.¹,Leval Amy¹³,Eklund Martin¹,Nordström Tobias¹^ORCID,Eloranta Sandra⁴,Schain Frida³⁵,Dearden Lindsay³,Liwing Johan³,Mehra Maneesha³,Nair Sandhya³,Pettersson Andreas⁶⁷,Akre Olof⁶⁷^ORCID,Aly Markus¹⁶⁷

Affiliation:

1. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

2. Department of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

3. Janssen Global Services, Solna, Sweden

4. Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden

5. Schain Research, Bromma, Sweden

6. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

7. Department of Pelvic Cancer, Cancer Theme, Karolinska University Hospital, Stockholm, Sweden

Funder

public–private real-world evidence collaboration between Karolinska Institutet and Janssen Pharmaceuticals

Swedish Research Council

Swedish Cancer Society

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21681805.2021.1936626

Reference32 articles.

1. Cancer statistics, 2019

2. Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)

3. Global Cancer Observatory, International Agency for Research on Cancer, World Health Organization. 2018. May 1, 2020]; Available from: https://gco.iarc.fr/

4. Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction

5. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost Analysis of Prostate Cancer Care Using a Biomarker-enhanced Diagnostic Strategy with Stockholm3;European Urology Open Science;2024-08

2. Symptoms and quality of life among men starting treatment for metastatic castration-resistant prostate cancer – a prospective multicenter study;BMC Palliative Care;2024-03-27

3. Real-World Treatment Patterns Among French Patients With Metastatic Castration-Resistant Prostate Cancer Under Abiraterone or Enzalutamide;Clinical Genitourinary Cancer;2023-10

4. Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study;Acta Oncologica;2023-09-19

5. Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis;Urologic Oncology: Seminars and Original Investigations;2023-04